(Diridavumab)Biosimilar Reference Antibody-GS40184

货号：GS40184

Diridavumab is a human monoclonal antibody that targets the hemagglutinin (HA) protein of influenza A virus, with a focus on the relatively conserved HA2 subunit. This antibody is being developed as a broad-spectrum therapeutic and prophylactic agent against multiple strains of influenza A. By binding to a conserved region of the virus, it aims to provide protection that transcends the seasonal genetic drift of influenza, potentially offering a universal or near-universal countermeasure against influenza A infections.